These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16791380)

  • 21. Neurocysticercosis in Wisconsin: 3 cases and a review of the literature.
    Naddaf E; Seeger SK; Stafstrom CE
    WMJ; 2014 Apr; 113(2):74-8; quiz 79. PubMed ID: 24908903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difficult to control epilepsy in young female: a common problem in a low resource setting.
    Segamwenge IL; Kioko NP
    Pan Afr Med J; 2014; 18():212. PubMed ID: 25419338
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurocysticercosis.
    Schlaen BR; Asad S; Neill MA
    Med Health R I; 2005 Apr; 88(4):127. PubMed ID: 15974050
    [No Abstract]   [Full Text] [Related]  

  • 24. ELISA in the evaluation of therapeutic response to albendazole in neurocysticercosis.
    Husain N; Shukla N; Kumar R; Husain M; Chaturvedi A; Agarwal GG; Gupta RK
    J Infect; 2008 Jan; 56(1):65-73. PubMed ID: 17988742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ecuadorian immigrant with headache].
    Ortega-Herrera R; Fernández-Segura ME; Gómez de Travecedo Y Calvo I
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):248-9. PubMed ID: 15056443
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurocysticercosis with Diplopia Responds Well to Albendazole.
    Sato A; Nakamura I; Fujita H; Fukushima S; Mizuno Y; Fujii T; Matsumoto T
    Intern Med; 2016; 55(9):1219-22. PubMed ID: 27150884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
    Singhi P; Jain V; Khandelwal N
    J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case from India of neurocysticercosis responsive to albendazole treatment.
    Zardi EM; Petrarca V; Pozio E; Uwechie V; Tamburrini A; Laghi V
    Parasite; 2000 Mar; 7(1):54-6. PubMed ID: 10743650
    [No Abstract]   [Full Text] [Related]  

  • 29. A rare presentation of neurocysticercosis in a young child.
    Scott JX; Devi A; Kumar TS; Moses PD
    J Trop Pediatr; 2005 Aug; 51(4):254-5. PubMed ID: 16014765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P; Dayal D; Khandelwal N
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior divisional oculomotor nerve palsy caused by midbrain neurocysticercosis.
    Chotmongkol V; Sawanyawisuth K; Limpawattana P; Phuphatham A; Chotmongkol R; Intapan PM
    Parasitol Int; 2006 Sep; 55(3):223-5. PubMed ID: 16737842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of 32 cases with neurocysticercosis in children].
    Guo CY; Yang HM; Ma GR
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):187. PubMed ID: 16300019
    [No Abstract]   [Full Text] [Related]  

  • 33. Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution.
    de Souza A; Nalini A; Kovoor JM; Yeshraj G; Siddalingaiah HS; Thennarasu K
    J Neurol Sci; 2010 Jan; 288(1-2):135-41. PubMed ID: 19875133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory aneurysm and neurocysticercosis: further evidence for a causal relationship? Case report.
    Huang PP; Choudhri HF; Jallo G; Miller DC
    Neurosurgery; 2000 Aug; 47(2):466-7; discussion 467-8. PubMed ID: 10942024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Be careful while using albendazole/praziquantel in neurocysticercosis.
    Garg RK; Uniyal R; Malhotra HS
    Neurol India; 2017; 65(4):924-926. PubMed ID: 28681797
    [No Abstract]   [Full Text] [Related]  

  • 36. Millairy neurocysticercosis.
    Sundaresan S; Sanklecha M
    J Pediatr; 2014 Dec; 165(6):1270-1270.e2. PubMed ID: 25179531
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infectious ventriculitis in relation with neurocysticercosis in Burkina Faso].
    Napon C; Maïga Y; Diallo O; Kaboré J
    Rev Neurol (Paris); 2011; 167(8-9):632-4. PubMed ID: 21481903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
    Carpio A; Kelvin EA; Bagiella E; Leslie D; Leon P; Andrews H; Hauser WA;
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1050-5. PubMed ID: 18495737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocysticercosis and human immunodeficiency virus infection: a case report.
    Chianura L; Sberna M; Moioli C; Villa MR; Orcese C; Causarano R
    J Travel Med; 2006; 13(6):376-80. PubMed ID: 17107432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report.
    Kobayashi E; Guerreiro CA; Cendes F
    Arq Neuropsiquiatr; 2001 Jun; 59(2-A):255-8. PubMed ID: 11400037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.